⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8061118 | 0.80 | TDP1 (0.43) | — | |
| SCHEMBL18743786 | 0.79 | — | — | |
| SCHEMBL10207609 | 0.78 | — | — | |
| SCHEMBL10207613 | 0.78 | — | — | |
| SCHEMBL2556696 | 0.78 | — | — | |
| SCHEMBL1581176 | 0.78 | — | — | |
| SCHEMBL164712 | 0.78 | — | — | |
| SCHEMBL13774332 | 0.78 | — | — | |
| SCHEMBL22290525 | 0.76 | — | — | |
| SCHEMBL16267280 | 0.76 | MME (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3122768-A2 | T-CELL RECEPTOR CDR3 PEPTIDES AND ANTIBODIES | Yeda Research and Development Co. Ltd. (IL) | 2017-02-01 | — | — | EP | disclosed |
| WO-2015145449-A2 | T-CELL RECEPTOR CDR3 PEPTIDES AND ANTIBODIES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2015-10-01 | — | — | WO | disclosed |
| EP-2342334-A1 | TUMOR VASCULAR MARKER-TARGETED VACCINES | The Trustees Of The University Of Pennsylvania (US) | 2011-07-13 | — | — | EP | disclosed |
| WO-2010037124-A1 | TUMOR VASCULAR MARKER-TARGETED VACCINES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2010-04-01 | — | — | WO | disclosed |
| WO-2010019995-A1 | THE ERG TRANSCRIPTION FACTOR MODULATION OF VASCULAR DEVELOPMENT | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2010-02-25 | — | — | WO | disclosed |
| EP-2091967-A1 | CRYSTALLINE COMPOSITION OF GM-CSF/GM-CSFR | St. Vincent's Institute of Medical Research (AU) | 2009-08-26 | — | — | EP | disclosed |
| EP-1844069-A4 | MOLECULES AND CHIMERIC MOLECULES THEREOF | APOLLO LIFE SCIENCES LTD (AU) | 2009-05-20 | — | — | EP | disclosed |
| EP-1910535-A4 | THERAPEUTIC PRO-APOPTOTIC BH3-LIKE MOLECULES AND METHODS FOR GENERATING AND/OR SELECTING THE SAME | INST MEDICAL W & E HALL (AU) | 2009-05-20 | — | — | EP | disclosed |
| WO-2008086573-A1 | USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2008-07-24 | — | — | WO | disclosed |
| WO-2008077194-A1 | RECEPTOR AGONISTS | XENOME LTD (AU) | 2008-07-03 | — | — | WO | disclosed |
| WO-2007025347-A1 | PROPHYLACTIC AND THERAPEUTIC AGENTS AND USES THEREFOR | HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) | 2007-03-08 | — | — | WO | disclosed |
| WO-2006135985-A1 | THERAPEUTIC PRO-APOPTOTIC BH3-LIKE MOLECULES AND METHODS FOR GENERATING AND/OR SELECTING THE SAME | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006129320-A2 | BIODEGRADABLE POLYMERS HAVING A PRE-DETERMINED CHIRALITY | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-12-07 | — | — | WO | disclosed |
| WO-2006122363-A1 | THERAPEUTIC AGENTS AND TARGETS | AUTOGEN RESEARCH PTY LTD (AU) | 2006-11-23 | — | — | WO | disclosed |
| WO-2006108211-A1 | FRAGMENTS OF VON WILLEBRAND FACTOR A-RELATED PROTEIN | THE MURDOCH CHILDRENS RESEARCH INSTITUTE (AU) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006079176-A1 | MOLECULES AND CHIMERIC MOLECULES THEREOF | APOLLO LIFE SCIENCES LIMITED (AU) | 2006-08-03 | — | — | WO | disclosed |
| WO-2006060871-A1 | BINDING PARTNERS OF ANTIBODIES SPECIFIC FOR DENDRITIC CELL ANTIGENS | THE CORPORATION OF THE TRUSTEES OF THE ORDER OF THE SISTERS OF MERCY IN QUEENSLAND (AU) | 2006-06-15 | — | — | WO | disclosed |
| WO-2006029462-A1 | A NUCLEIC ACID MOLECULE DIFFERENTIALLY EXPRESSED IN A MOUSE BEHAVIOURAL MODEL SYSTEM AND USES THEREOF | AUTOGEN RESEARCH PTY LTD (AU) | 2006-03-23 | — | — | WO | disclosed |
| WO-2006026820-A1 | TREATING GLIOSIS, GLIAL SCARRING, INFLAMMATION OR INHIBITION OF AXONAL GROWTH IN THE NERVOUS SYSTEM BY MODULATING EPH RECEPTOR | THE UNIVERSITY OF QUEENSLAND (AU) | 2006-03-16 | — | — | WO | disclosed |
| WO-2006007667-A1 | THERAPEUTIC AND DIAGNOSTIC AGENTS | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-01-26 | — | — | WO | disclosed |